EBElif Baris

Elif Baris

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elif Baris has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of CDP-Choline and Choline on Gastrointestinal Inflammatory and Monoaminergic Responses in an LPS-Induced Rat Endotoxemia Model

    by Shideh Roshani, Elif Baris, Emre Hamurtekin, Candan Ozogul, Ahmet Sami Bosnak

    Objectives: Endotoxemia is associated with pronounced gastrointestinal (GI) inflammatory responses and disruption of local neurochemical regulation. Although cytidine-5′-diphosphocholine (CDP-choline) and choline exert anti-inflammatory effects, their region-specific actions on GI inflammation and monoaminergic alterations during endotoxemia remain poorly characterized. Methods: Acute endotoxemia was induced in female Sprague–Dawley rats by intraperitoneal lipopolysaccharide (LPS; 10 mg/kg). Endotoxemia severity was assessed using a standardized sepsis scoring system at 6 and 24 h. GI tissues (esophagus, stomach, duodenum, cecum, and colon) were analyzed for tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), choline acetyltransferase (ChAT), serotonin (5-HT), dopamine (DA), and norepinephrine (NE) by ELISA, alongside histopathological evaluation. Results: LPS significantly elevated sepsis scores, cytokine levels, and monoamine concentrations across all GI regions, with the most pronounced cytokine responses in the duodenum, cecum, and esophagus. CDP-choline attenuated TNF-α and IL-6 elevations more effectively than choline; markedly increased ChAT levels, especially in the esophagus, cecum, and colon; and reduced LPS-induced 5-HT and DA elevations in a region-dependent manner. NE responses were heterogeneous across regions. Histopathologically, CDP-choline largely preserved normal tissue architecture throughout the GI tract, whereas choline provided only partial protection in intestinal tissues. Conclusions: CDP-choline exerted stronger modulatory effects than choline on region-specific GI inflammatory, cholinergic, and monoaminergic responses during acute endotoxemia, supporting further investigation of cholinergic precursors as modulators of GI neuroimmune dysfunction in systemic inflammation.

  • The Effect of Choline on Viability in Prostate Carcinoma Cells: Possible Involvement of Cholinergic Regulation

    by Yasemen Adalı Ruşen, Elif Barış

    Background and Purpose: Prostate carcinoma is a frequently encountered tumor, and due to its relatively long survival period, early diagnosis, treatment, and follow-up are crucial in this cancer. Changes in the tumor microenvironment, including neural alterations, have drawn attention to their effects on treatment and prognosis. The mechanism of neural effects, such as acetylcholine (ACh), in prostate cancer is not yet fully elucidated. The aim of this research is to investigate the possible interaction of choline on cell viability in prostate carcinoma cells. The aim of this study to investigate the effects of choline in normal prostate cells and cells of prostate carcinoma. Methods: DU145 human prostate epithelial carcinoma cells and PNT1a human prostate epithelial normal cell lines were treated with increasing concentrations of choline (0.5-2.5-5-25-50-75-100 µM) and viability analysis using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method.Results: Our preliminary results showed that choline suppressed the viability of prostate carcinoma cells at concentrations of 50µM and higher however, viability in normal prostate cells remained unchanged. Conclusion: Although further analyses are needed, our results demonstrate that choline might have potential therapeutic effects in prostate carcinoma without effecting normal prostate cells.

  • Effects of varenicline as an adjunct to analgesic and anti-inflammatory therapy in acute nerve injury

    by Volga Ozturk, Yasemen Adali Rusen, Ozge Ertener, Yasemin Seval-Celik, Ali Engin Dastan, Serhat Ozgenc, Elif Baris


  • Enhancement of Corchorus olitorius L. on osteogenic differentiation of MC3T3-E1 pre-osteoblast cells by increasing alkaline phosphatase and hydroxyproline

    by Pinar Ertugruloglu, Elif Baris, Gaye Sumer Okkali, Nazli Boke Sarikahya

    Corchorus olitorius L. (jute mallow or molehiya) belongs to the Malvaceae family valued for its nutritional and medicinal properties. In this study, the potential to enhance osteogenesis in MC3T3-E1(Murine Calvaria-derived 3T3 Subclone E1) pre-osteoblastic cells was investigated to support bone formation and mineralisation. Leaf ethanolic extract was prepared and applied to MC3T3-E1 cells. Osteogenic effects were evaluated through three methods: MTT assays for cell viability, Alizarin Red S staining for calcium deposition, enzymatic analyses for alkaline phosphatase (ALP) and hydroxyproline (HYP). A non-cytotoxic concentration of C. olitorius extract (0.5 mg/mL) significantly increased ALP and HYP levels, promoting osteogenic differentiation in both undifferentiated and differentiated cells. HYP levels were notably elevated in differentiated cells. The findings suggested that C. olitorius extract may be a promising natural agent for enhancing bone health, warranting further in vivo and clinical studies to confirm its therapeutic potential.

  • Open Access

    Liraglutide modulates cyclooxygenase and α7 acetylcholine receptors: in vitro and in silico insights into its anti-inflammatory role in LPS-induced inflammation in RAW 264.7 macrophages

    by Elif Baris, Huseyin Saygin Portakal, Arda Aslan, Zeynep Firtina Karagonlar, Metiner Tosun

    Liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is well-established for its metabolic benefits, including glycemic control and weight loss. Beyond these roles, it exhibits significant anti-inflammatory properties, though the mechanisms remain underexplored. This study investigates the anti-inflammatory effects of liraglutide in lipopolysaccharide (LPS)-stimulated RAW 264.7 murine macrophages. Results demonstrate that increasing concentrations of liraglutide suppresses LPS-elevated prostaglandin E2 (PGE2), 6-keto prostaglandin F1α (6-keto-PGF 1α , a stable prostacyclin metabolite) and thromboxane A2 (TXA2), similar to that observed with conventional anti-inflammatory agents, ibuprofen and celecoxib. Mechanistic exploration reveals that liraglutide's anti-inflammatory action is dually-modulated by cyclooxygenase (COX) and nicotinic acetylcholine receptor (nAChR) signaling. The application of non-selective, non-competitive nAChR antagonist or selective and potent α7-nAChR antagonist, mecamylamine (MEC) and methyllycaconitine (MLA), respectively, highlights the involvement of cholinergic pathways in liraglutide's activity. Based on in silico molecular docking analyses, liraglutide exhibits favorable binding affinities to COX-1, COX-2, prostacyclin synthase (PGIS), and α7nAChRs, supporting its potential multi-target anti-inflammatory effects. These findings suggest that the therapeutic potential of liraglutide may go beyond metabolic regulation and may be promising for conditions in which metabolic and inflammatory pathways converge, including inflammation and modulation of cholinergic signaling.


  • Open Access

    Complications and therapeutic approaches in a sciatic nerve injury rat model

    by Volga Öztürk, Ali Engin Dastan, Yasemen Adalı Ruşen, Elif Barış

    Sciatic nerve injury (SNI) is a common model for studying peripheral nerve damage and regeneration. This study investigates the complications associated with acute nerve injury (ANI) by laceration of sciatic nerve in rats including infection, edema, and cannibalism, and evaluates the effectiveness of therapeutic interventions to modulate the observed complications. For this purpose eighteen female wistar albino rats were divided into three groups: control, sham-operated, and ANI. The ANI model induced with dissection and repair of the right sciatic nerve. Post-surgical care included the administration of diclofenac sodium for pain management. Observations were made for signs of infection, edema, hematoma, and survival rates within 10 days. The ANI group showed significant complications, including a 41.6% incidence of symptoms of pain (paraesthesia, allodynia, hyperalgesia, decreased activity, piloerection, excessive licking, un-groomed appearance) within 3 days, which increased to 60% by day 5. Edema was observed in 8.3% of the ANI rats, and 33.3% developed hematomas. Cannibalism rates also increased, particularly within 10 days post-injury. Survival rates in the ANI group decreased to 16.6% by day 10, indicating severe post-operative complications. The current study highlights the critical complications associated with ANI in rats, particularly the high rates of pain related symptoms (i.e. paresthesia and cannibalism). These findings suggest the need for improved post-operative care and highlight the importance of therapeutic interventions like opioid analgesics to mitigate these complications and enhance recovery outcomes in peripheral nerve injury models.


  • Open Access

    Investigation of Changes in Blood Choline Levels in Individuals Diagnosed with Osteoporosis: A Case–Control Study

    by Volga Ozturk, Elif Baris

    Objectives: This study aimed to compare blood choline levels and its correlations with bone mineral density (BMD) calcium, vitamin D, and parathyroid hormone (PTH) in patients with osteoporosis and healthy controls. Background: Osteoporosis is a condition marked by reduced bone density and a higher risk of fractures, posing a major health concern. Cholinergic activity promotes bone formation, while its inhibition may contribute to bone loss. Methods: Blood choline levels in 64 female participants, 38 with osteoporosis and 26 healthy controls. were measured using ELISA, and BMD was assessed via Dual-Energy X-Ray Absorptiometry (DEXA). Additional biochemical markers, including calcium, vitamin D, and PTH, were analyzed. Results: Blood choline levels were significantly lower in the osteoporosis group compared to controls. Moderate correlations were observed between choline levels and BMD, as well as weak correlations with calcium, vitamin D, and PTH in patients with osteoporosis. Conclusion: Lower choline levels in osteoporosis patients suggest a potential link between cholinergic deficiency and the disease, emphasizing the need for further research into cholinergic therapies for osteoporosis.


  • Preventative effect of montelukast in mild to moderate contrast-induced acute kidney injury in rats via NADPH oxidase 4, p22phox and nuclear factor kappa-B expressions

    by Oguzhan Simsek, Elif Baris, Cemre Ural, Canet Incir, Selma Aydemir, Mukaddes Gumustekin, Zahide Cavdar, Osman Yilmaz, Seda Ozbal, Mualla Aylin Arici

    Reactive oxygen species (ROS) generation, inflammation and apoptosis are observed in contrast-induced acute kidney injury (CI-AKI). NOX4, isoform of NADPH oxidase main regulatory enzyme for ROS generation, is mostly expressed in the kidney and co-localized with p22phox. It is investigated the effect of antioxidant, anti-inflammatory and anti-apoptotic montelukast pre-treatment on expression of NOX4, p22phox and NF-κB in preventing CI-AKI in rats in this study. Wistar male rats randomized into four groups: 1. Control (C), 2. CI-AKI (iohexol; 3 g iodine/kg), 3. Montelukast (10 mg/kg) (M), 4. M + CI-AKI. Rats sacrificed on the 7th day. Urine and serum creatinine and serum Kidney injury molecule-1 (KIM-1) levels measured. NF-κB, NOX-4, p22phox mRNA and protein expressions, TNF-α, KIM-1 mRNA expressions, ROS and caspase-3 evaluated from kidney tissue. Histological injury scored. ANOVA and Kruskal–Wallis tests were used for analysis parametric and nonparametric data, respectively. p < 0.05 considered statistically significant. Tubular injury score, KIM-1 and caspase-3 levels increased in CI-AKI group compared to C group (p < 0.05). TNF-α, NF-κB, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels increased in CI-AKI group compared to C group (p < 0.001 and p < 0.05). NF-κB, NOX-4, p22phox protein expressions increased in CI-AKI group compared to C group (p < 0.05) and decreased in the M + CI-AKI group compared to CI-AKI group (p < 0.01, p < 0.05, p < 0.05). TNF-α, NF-κB, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels decreased with montelukast pre-treatment (p < 0.001). One of the mechanism of increased ROS level in the CI-AKI model is related the increase the expression of NOX4 and p22phox and montelukast pre-treatment has a protective effect by decreasing NOX4 and p22phox mRNA and protein expressions.


  • Solid Organ Nakli Farmakolojisi ve Hemşirelik Yönetimi

    by Özge İşEri, Elif Barış

    Organ ve doku naklinde immunosupresif tedavi nakledilen organın reddini önleyerek, alıcının sağ kalımını arttırmaktadır. Her merkezin tedavi protokolü farklı olmakla birlikte en çok tercih edilen tedavi şekli takrolimus veya siklosporin gibi kalsinörin inhibitörleri, mikofenolat veya azatioprin gibi pürin sentezi inhibitörleri ile glukokortikoidleri içeren üçlü kombinasyonların kullanımıdır. Bu ilaçlar, grefti rejeksiyondan korusa da birçok yan etkiye de sahiptir. Bu nedenle hastalarda oluşabilecek komplikasyonların izlemi, önlenmesi, hastaların eğitimi ve immunosupresif ilaçlara uyumun sağlanması oldukça önemlidir. Bu noktada organ nakil ekibinin farkındalığı ve yakın takibi çok değerlidir. Hemşireler de bu süreçte kilit konumda yer almaktadır. Bu bölümde immunosupresif ilaçlar, ilaçların etki ve yan etki mekanizmaları ele alınarak hemşirelik yönetimi incelenecektir.

  • Open Access

    Solid Organ Naklinde Hemşirelik Bakımı

    by Adam Uslu, F. Sevgi Hatipoğlu, Murat Karataş, Nazife Gamze Özer Özlü, Levent Yücetin, Arzu Kader Harmancı Seren, Buket Çelik, Can Karaca, Tuğçe Zeyrek, Aylin Durmaz Edeer, et al.

    Solid Organ Nakli Tarihçesi Adam USLU, F. Sevgi HATİPOĞLU, Yaprak SARIGÖL ORDİN, Murat KARATAŞ Organ Naklinde Temel Kavramlar Nazife Gamze ÖZER ÖZLÜ, Yaprak SARIGÖL ORDİN Solid Organ Nakli İle İlgili Yasal Düzenlemelerve Türkiye Ulusal Koordinasyon Sistemi Levent YÜCETİN, Arzu Kader HARMANCI SEREN Solid Organ Naklinde Etik ve Hemşirenin Rolü Buket ÇELİK Solid Organ Naklinde Multidisipliner Bakım Yaklaşımı Can KARACA, Tuğçe ZEYREK Solid Organ Nakli Alıcısının Hazırlığı Aylin DURMAZ EDEER, Adile SAVSAR Solid Organ Nakli İmmünolojisi Gökhan AYGÜN, Pakize AYGÜN Solid Organ Nakli Farmakolojisi ve Hemşirelik Yönetimi Özge İŞERİ, Elif BARIŞ Solid Organ Naklinde Enfeksiyon Hastalıklarıve Hemşirelik Bakımı Sibel NARGİZ KOŞUCU, Arife ALTIN ÇETİN, Ayla GÜRSOY, Umay BALCI Böbrek Nakli ve Hemşirelik Bakımı Böbrek Nakli Cerrahi Süreci Hakan ÖZDEMİR, İbrahim BERBER Böbrek Nakli Öncesi ve Sonrası Hemşirelik Bakımı Serap ARICAN, Canan BAKAN Karaciğer Nakli ve Hemşirelik Bakımı Karaciğer Nakli Cerrahi Süreci Rasim FARAJOV, Murat KILIÇ Karaciğer Nakli Öncesi ve Sonrası Hemşirelik Bakımı Bilsev DEMİR, Nebile ÇUBUK Kalp Nakli ve Hemşirelik Bakımı Kalp Nakli Cerrahi Süreci Halit ER, Serap AYKUT AKA Kalp Nakli Öncesi ve Sonrası Hemşirelik Bakımı Fatma DEMİR KORKMAZ, Tuğba Nur ÖDEN Akciğer Nakli ve Hemşirelik Bakımı Akciğer Nakli Cerrahi Süreci Ali ÖZDİL, Gizem KEÇECİ ÖZGÜR Akciğer Nakli Öncesi ve Sonrası Hemşirelik Bakımı Eda Ayten KANKAYA Pankreas Nakli ve Hemşirelik Bakımı Deniz ŞANLI, Gülten SUCU DAĞ Solid Organ Nakli Sonrası Uzun Dönem Komplikasyonlar ve Hemşirelik Bakımı Bahar ASLAN DOĞAN, Sedef SELÇUK TOPBAŞ, Didem KANDEMİR Canlı Verici Bakımı Esma ÖZŞAKER, Rukiye İNAL, Ebru GÜLCAN Solid Organ Nakli Alıcısında Psikososyal Sorunlar ve Hemşirelik Bakımı Nilgün AKSOY, Büşra Nur TEMÜR Solid Organ Nakli Canlı Vericisinde Psikososyal Sorunlar ve Hemşirelik Bakımı Burcu ARKAN, Gülfer PEHLİVAN, Şirin DURMUŞ Solid Organ Nakli Alıcı ve Verici Eğitimi Büşra Selma SAHA, Nurşen ALTUĞ, Sinem ARAS Pediatrik Organ Nakilleri Öncesi ve Sonrası Hemşirelik Bakımı Rabiye GÜNEY, Duygu YILMAZ Yaşlılarda Organ Naklinde Öncesi ve Sonrası Hemşirelik Bakımı Hale TURHAN DAMAR Solid Organ Nakli Sonrası Cinsel Yaşam, Doğum Kontrol Yöntemleri, Gebelik ve Emzirme Özgül KARAYURT, Adile SAVSAR Solid Organ Transplantasyonu ile İlgili Kurum, Kuruluşlar ve Bilgi Kaynakları Yaprak SARIGÖL ORDİN